New drug combo may reduce side effects in kidney transplant patients
NCT ID NCT02711202
First seen Apr 19, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study tested a new drug plan for 20 kidney transplant patients to prevent organ rejection while avoiding some common side effects. The approach used two powerful antibodies right after transplant, followed by just one maintenance drug instead of the usual combination. The goal was to see if patients and their new kidneys stayed healthy with fewer medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.